Cargando…
Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions
OBJECTIVE: To determine whether MRI gadolinium enhancement patterns in myelopathies with longitudinally extensive T2 lesions can be reliably distinguished and assist in diagnosis. METHODS: We retrospectively identified 74 Mayo Clinic patients (January 1, 1996–December 31, 2019) fulfilling the follow...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610516/ https://www.ncbi.nlm.nih.gov/pubmed/34824894 http://dx.doi.org/10.1212/CPJ.0000000000001036 |
_version_ | 1784603121124638720 |
---|---|
author | Mustafa, Rafid Passe, Theodore J. Lopez-Chiriboga, Alfonso S. Weinshenker, Brian G. Krecke, Karl N. Zalewski, Nicholas L. Diehn, Felix E. Sechi, Elia Mandrekar, Jay Kaufmann, Timothy J. Morris, Padraig P. Pittock, Sean J. Toledano, Michel Lanzino, Giuseppe Aksamit, Allen J. Kumar, Neeraj Lucchinetti, Claudia F. Flanagan, Eoin P. |
author_facet | Mustafa, Rafid Passe, Theodore J. Lopez-Chiriboga, Alfonso S. Weinshenker, Brian G. Krecke, Karl N. Zalewski, Nicholas L. Diehn, Felix E. Sechi, Elia Mandrekar, Jay Kaufmann, Timothy J. Morris, Padraig P. Pittock, Sean J. Toledano, Michel Lanzino, Giuseppe Aksamit, Allen J. Kumar, Neeraj Lucchinetti, Claudia F. Flanagan, Eoin P. |
author_sort | Mustafa, Rafid |
collection | PubMed |
description | OBJECTIVE: To determine whether MRI gadolinium enhancement patterns in myelopathies with longitudinally extensive T2 lesions can be reliably distinguished and assist in diagnosis. METHODS: We retrospectively identified 74 Mayo Clinic patients (January 1, 1996–December 31, 2019) fulfilling the following criteria: (1) clinical myelopathy; (2) MRI spine available; (3) longitudinally extensive T2 hyperintensity (≥3 vertebral segments); and (4) characteristic gadolinium enhancement pattern associated with a specific myelopathy etiology. Thirty-nine cases with alternative myelopathy etiologies, without previously described enhancement patterns, were included as controls. Two independent readers, educated on enhancement patterns, reviewed T2-weighted and postgadolinium T1-weighted images and selected the diagnosis based on this knowledge. These were compared with the true diagnoses, and agreement was measured with Kappa coefficient. RESULTS: Among all cases and controls (n = 113), there was excellent agreement for diagnosis using postgadolinium images (kappa, 0.76) but poor agreement with T2-weighted characteristics alone (kappa, 0.25). A correct diagnosis was more likely when assessing postgadolinium image characteristics than with T2-weighted images alone (rater 1: 100/113 [88%] vs 61/113 [54%] correct, p < 0.0001; rater 2: 95/113 [84%] vs 68/113 [60%] correct, p < 0.0001). Of the 74 with characteristic enhancement patterns, 55 (74%) were assigned an alternative incorrect or nonspecific diagnosis when originally evaluated in clinical practice, 12 (16%) received immunotherapy for noninflammatory myelopathies, and 2 (3%) underwent unnecessary spinal cord biopsy. CONCLUSIONS: Misdiagnosis of myelopathies is common. The gadolinium enhancement patterns characteristic of specific diagnoses can be identified with excellent agreement between raters educated on this topic. This study highlights the potential diagnostic utility of enhancement patterns in myelopathies with longitudinally extensive T2 lesions. |
format | Online Article Text |
id | pubmed-8610516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-86105162021-11-24 Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions Mustafa, Rafid Passe, Theodore J. Lopez-Chiriboga, Alfonso S. Weinshenker, Brian G. Krecke, Karl N. Zalewski, Nicholas L. Diehn, Felix E. Sechi, Elia Mandrekar, Jay Kaufmann, Timothy J. Morris, Padraig P. Pittock, Sean J. Toledano, Michel Lanzino, Giuseppe Aksamit, Allen J. Kumar, Neeraj Lucchinetti, Claudia F. Flanagan, Eoin P. Neurol Clin Pract Research OBJECTIVE: To determine whether MRI gadolinium enhancement patterns in myelopathies with longitudinally extensive T2 lesions can be reliably distinguished and assist in diagnosis. METHODS: We retrospectively identified 74 Mayo Clinic patients (January 1, 1996–December 31, 2019) fulfilling the following criteria: (1) clinical myelopathy; (2) MRI spine available; (3) longitudinally extensive T2 hyperintensity (≥3 vertebral segments); and (4) characteristic gadolinium enhancement pattern associated with a specific myelopathy etiology. Thirty-nine cases with alternative myelopathy etiologies, without previously described enhancement patterns, were included as controls. Two independent readers, educated on enhancement patterns, reviewed T2-weighted and postgadolinium T1-weighted images and selected the diagnosis based on this knowledge. These were compared with the true diagnoses, and agreement was measured with Kappa coefficient. RESULTS: Among all cases and controls (n = 113), there was excellent agreement for diagnosis using postgadolinium images (kappa, 0.76) but poor agreement with T2-weighted characteristics alone (kappa, 0.25). A correct diagnosis was more likely when assessing postgadolinium image characteristics than with T2-weighted images alone (rater 1: 100/113 [88%] vs 61/113 [54%] correct, p < 0.0001; rater 2: 95/113 [84%] vs 68/113 [60%] correct, p < 0.0001). Of the 74 with characteristic enhancement patterns, 55 (74%) were assigned an alternative incorrect or nonspecific diagnosis when originally evaluated in clinical practice, 12 (16%) received immunotherapy for noninflammatory myelopathies, and 2 (3%) underwent unnecessary spinal cord biopsy. CONCLUSIONS: Misdiagnosis of myelopathies is common. The gadolinium enhancement patterns characteristic of specific diagnoses can be identified with excellent agreement between raters educated on this topic. This study highlights the potential diagnostic utility of enhancement patterns in myelopathies with longitudinally extensive T2 lesions. Lippincott Williams & Wilkins 2021-10 /pmc/articles/PMC8610516/ /pubmed/34824894 http://dx.doi.org/10.1212/CPJ.0000000000001036 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Research Mustafa, Rafid Passe, Theodore J. Lopez-Chiriboga, Alfonso S. Weinshenker, Brian G. Krecke, Karl N. Zalewski, Nicholas L. Diehn, Felix E. Sechi, Elia Mandrekar, Jay Kaufmann, Timothy J. Morris, Padraig P. Pittock, Sean J. Toledano, Michel Lanzino, Giuseppe Aksamit, Allen J. Kumar, Neeraj Lucchinetti, Claudia F. Flanagan, Eoin P. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions |
title | Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions |
title_full | Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions |
title_fullStr | Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions |
title_full_unstemmed | Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions |
title_short | Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions |
title_sort | utility of mri enhancement pattern in myelopathies with longitudinally extensive t2 lesions |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610516/ https://www.ncbi.nlm.nih.gov/pubmed/34824894 http://dx.doi.org/10.1212/CPJ.0000000000001036 |
work_keys_str_mv | AT mustafarafid utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT passetheodorej utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT lopezchiribogaalfonsos utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT weinshenkerbriang utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT kreckekarln utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT zalewskinicholasl utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT diehnfelixe utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT sechielia utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT mandrekarjay utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT kaufmanntimothyj utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT morrispadraigp utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT pittockseanj utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT toledanomichel utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT lanzinogiuseppe utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT aksamitallenj utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT kumarneeraj utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT lucchinetticlaudiaf utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions AT flanaganeoinp utilityofmrienhancementpatterninmyelopathieswithlongitudinallyextensivet2lesions |